Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

A Retrospective Study of Real World Data for stable wet AMD treatment with aflibercept

Maria K Gemenetzi; Praveen Patel; Shweta Anand; Marko Lukic; Simona Degli Esposti; Pearse Andrew Keane; Ella Preston; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1162. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Treat-and-extend Aflibercept in the treatment of macular edema due to CRVO: 18 months results of real life data

Theodora Gkika; Ella Preston; Robin Hamilton; Peter Addison; Bishwanath Pal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2575. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Patient-centred care in glaucoma: the patients’ perspective

Panayiota Founti; Urvi Patel; Rashmi Mathew; Anita Aubrey; Ella Preston; Tim Withers; Narciss Okhravi; Eleni Nikita

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4468. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Ranibizumab and Aflibercept: Baseline and 12-month visual outcomes of patients at a large tertiary ophthalmic hospital

Siegfried K Wagner; Katrin Fasler; Farid Afshar; Reena Chopra; Karsten Ulrich Kortuem; Nikolas Pontikos; Thushanthi Ramakrishnan; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):815. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Visual outcomes after 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital

Karsten Ulrich Kortuem; Thushanthi Ramakrishnan; Katrin Fasler; Reena Chopra; NIKOLAS PONTIKOS; Siegfried Wagner; Laxmi Raja; Hasaneen Al Janabi; Farid Afshar; Ella Preston; Praveen Patel; Adnan Tufail; Konstantinos Balaskas; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):838. doi: https://doi.org/

Advertisement